Managing Barrett's Esophagus
Barrett's esophagus is a condition in which normal cells that line the esophagus, called squamous cells, turn a different cell type called specialized columnar cells. Damage to the lining of the esophagus from gastroesophageal reflux disease causes the cells to change. Less than 1 percent of people with this condition develop cancer of the esophagus. However, having Barrett's esophagus may increase the risk of developing esophageal cancer.
Did you know?
- Approximately 10% of patients with chronic reflux have Barrett’s esophagus, and the prevalence of the condition in a recent population study was 1.6%. The condition is associated with an increased risk of esophageal cancer.
- The incidence of esophageal cancer has increased by more than 400% since the 1970s.
- The cancer remains highly lethal, with a 5-year survival rate of less than 15%.
Because of the reasons listed above, Beaumont is proud to offer the screening and treatment of Barrett's esophagus. We believe that prevention, screenings and early treatment will ultimately mean a longer, healthier life.
Whether you are currently a patient, have some symptoms of Barrett's esophagus and would like a screening or are a physician that would like to refer a patient, you can rest easy knowing that our expansive team of health care professionals will give you the analysis and knowledge you need.